Immunotherapy updates from WCLC 2021

Immunotherapy updates from WCLC 2021

Highlights in NSCLC from WCLC 2021Подробнее

Highlights in NSCLC from WCLC 2021

WCLC 2021 highlightsПодробнее

WCLC 2021 highlights

WCLC 2021 Behind the Scenes September 10 Press BriefingПодробнее

WCLC 2021 Behind the Scenes September 10 Press Briefing

Updates in immunotherapy for lung cancer at WCLC 2024Подробнее

Updates in immunotherapy for lung cancer at WCLC 2024

WCLC 2021 Behind the Scenes September 12 Press BriefingПодробнее

WCLC 2021 Behind the Scenes September 12 Press Briefing

IASC WCLC 2021: CX-2029 and AMG 757 for lung cancerПодробнее

IASC WCLC 2021: CX-2029 and AMG 757 for lung cancer

Highlights from WCLC 2021Подробнее

Highlights from WCLC 2021

BTOG 2021 highlights: immunotherapy for mesothelioma and cardiac toxicity updatesПодробнее

BTOG 2021 highlights: immunotherapy for mesothelioma and cardiac toxicity updates

Moving forward: targeted therapies in early-stage lung cancerПодробнее

Moving forward: targeted therapies in early-stage lung cancer

IASLC-WCLC 2021 Clinical PanelПодробнее

IASLC-WCLC 2021 Clinical Panel

Immunotherapy Updates in NSCLC: Front Line TherapyПодробнее

Immunotherapy Updates in NSCLC: Front Line Therapy

Reflecting on WCLC 2021Подробнее

Reflecting on WCLC 2021

Highlights of WCLC 2022Подробнее

Highlights of WCLC 2022

KEYNOTE-799: pembro + chemoradiotherapy in locally advanced NSCLCПодробнее

KEYNOTE-799: pembro + chemoradiotherapy in locally advanced NSCLC

Cancer Immunotherapy Workshop 2021 – Treatment Reporting GuidelinesПодробнее

Cancer Immunotherapy Workshop 2021 – Treatment Reporting Guidelines

WCLC 2021 HighlightsПодробнее

WCLC 2021 Highlights

NCIS ISOS 2021 - Immunotherapy: A Review and Updates for SurgeonsПодробнее

NCIS ISOS 2021 - Immunotherapy: A Review and Updates for Surgeons

Advances in perioperative immunotherapy in lung cancerПодробнее

Advances in perioperative immunotherapy in lung cancer